In this report, according to this study, over the next five years the Companion Animal Speciality Drugsmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Companion Animal Speciality Drugsbusiness.
Companion Animal Speciality Drugs market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Companion Animal Speciality Drugs for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Companion Animal Speciality Drugs market competition by top manufacturers/players, with Companion Animal Speciality Drugs sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Zoetis
Merck
Merial
Elanco
Bayer Animal Health
Boehringer Ingelheim Vetmedica
Virbac
Ceva Sante Animale
V?toquinol
Jurox
MSD Animal Health Australia
PARNELL
CAHIC
Ringpu Biology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Antibiotics
Anti-inflammatory Drugs
Parasiticides
Heartworm
Behavioural Products
Nutritional Products
Anti-Obesity Drugs
Skin Care Products
Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Companion Animal Speciality Drugs for each application, including
Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Companion Animal Speciality Drugs Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Antibiotics
2.1.2 Anti-inflammatory Drugs
2.1.3 Parasiticides
2.1.4 Heartworm
2.1.5 Behavioural Products
2.1.6 Nutritional Products
2.1.7 Anti-Obesity Drugs
2.1.8 Skin Care Products
2.1.9 Vaccines
2.2 Overall Market Performance(Value)
2.2.1 Antibiotics
2.2.2 Anti-inflammatory Drugs
2.2.3 Parasiticides
2.2.4 Heartworm
2.2.5 Behavioural Products
2.2.6 Nutritional Products
2.2.7 Anti-Obesity Drugs
2.2.8 Skin Care Products
2.2.9 Vaccines
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Veterinary Hospitals
3.1.2 Veterinary Clinics
3.1.3 Pharmacies and Drug Stores
4 Manufacturers Profiles/Analysis
4.1 Zoetis
4.1.1 Zoetis Profiles
4.1.2 Zoetis Product Information
4.1.3 Zoetis Companion Animal Speciality Drugs Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Zoetis SWOT Analysis
4.2 Merck
4.2.1 Merck Profiles
4.2.2 Merck Product Information
4.2.3 Merck Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Merck SWOT Analysis
4.3 Merial
4.3.1 Merial Profiles
4.3.2 Merial Product Information
4.3.3 Merial Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Merial SWOT Analysis
4.4 Elanco
4.4.1 Elanco Profiles
4.4.2 Elanco Product Information
4.4.3 Elanco Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Elanco SWOT Analysis
4.5 Bayer Animal Health
4.5.1 Bayer Animal Health Profiles
4.5.2 Bayer Animal Health Product Information
4.5.3 Bayer Animal Health Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Bayer Animal Health SWOT Analysis
4.6 Boehringer Ingelheim Vetmedica
4.6.1 Boehringer Ingelheim Vetmedica Profiles
4.6.2 Boehringer Ingelheim Vetmedica Product Information
4.6.3 Boehringer Ingelheim Vetmedica Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Boehringer Ingelheim Vetmedica SWOT Analysis
4.7 Virbac
4.7.1 Virbac Profiles
4.7.2 Virbac Product Information
4.7.3 Virbac Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Virbac SWOT Analysis
4.8 Ceva Sante Animale
4.8.1 Ceva Sante Animale Profiles
4.8.2 Ceva Sante Animale Product Information
4.8.3 Ceva Sante Animale Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Ceva Sante Animale SWOT Analysis
4.9 V?toquinol
4.9.1 V?toquinol Profiles
4.9.2 V?toquinol Product Information
4.9.3 V?toquinol Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 V?toquinol SWOT Analysis
4.10 Jurox
4.10.1 Jurox Profiles
4.10.2 Jurox Product Information
4.10.3 Jurox Companion Animal Speciality DrugsSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Jurox SWOT Analysis
4.11 MSD Animal Health Australia
4.12 PARNELL
4.13 CAHIC
4.14 Ringpu Biology
5 Market Performance for Manufacturers
5.1 Global Companion Animal Speciality Drugs Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Companion Animal Speciality Drugs Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Companion Animal Speciality Drugs Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Companion Animal Speciality Drugs Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Companion Animal Speciality Drugs Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Companion Animal Speciality Drugs Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Companion Animal Speciality Drugs Market Assessment by Regions (2014-2020)
7.1 Global Companion Animal Speciality Drugs Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Companion Animal Speciality Drugs Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Companion Animal Speciality Drugs Price (USD/Unit) by Regions 2014-2020
7.4 Global Companion Animal Speciality Drugs Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Companion Animal Speciality Drugs Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Veterinary Hospitals Industry
11.2 Veterinary Clinics Industry
11.3 Pharmacies and Drug Stores Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Companion Animal Speciality Drugs Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Companion Animal Speciality Drugs Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Antibiotics
12.2.3 Anti-inflammatory Drugs
12.2.4 Parasiticides
12.2.5 Heartworm
12.2.6 Behavioural Products
12.2.7 Nutritional Products
12.2.8 Anti-Obesity Drugs
12.2.9 Skin Care Products
12.2.10 Vaccines
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Veterinary Hospitals
12.3.3 Veterinary Clinics
12.3.4 Pharmacies and Drug Stores
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Companion Animal Speciality Drugs Price (USD/Unit) Trend 2021-2026
12.4.2 Global Companion Animal Speciality Drugs Gross Profit Trend 2021-2026
13 Conclusion